Menu
Search
|

Menu

Close
X

PolarityTE Inc COOL.OQ (NASDAQ Stock Exchange Capital Market)

21.22 USD
-1.37 (-6.06%)
As of Feb 16
chart
Previous Close 22.59
Open 22.65
Volume 39,063
3m Avg Volume 23,657
Today’s High 22.84
Today’s Low 21.01
52 Week High 32.63
52 Week Low 4.91
Shares Outstanding (mil) 6.33
Market Capitalization (mil) 169.50
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY17
0
FY16
1
FY15
7
EPS (USD)
FY17
-26.142
FY16
-5.373
FY15
-5.320
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
1,245.97
Price to Sales (TTM)
vs sector
265.25
2.88
Price to Book (MRQ)
vs sector
--
2.28
Price to Cash Flow (TTM)
vs sector
--
15.65
Total Debt to Equity (MRQ)
vs sector
0.00
16.61
LT Debt to Equity (MRQ)
vs sector
0.00
8.87
Return on Investment (TTM)
vs sector
-2,519.02
13.72
Return on Equity (TTM)
vs sector
--
13.64

EXECUTIVE LEADERSHIP

Denver Lough
Chairman of the Board, Chief Executive Officer, Chief Scientific Officer, Since 2016
Salary: --
Bonus: --
John Stetson
Chief Financial Officer, Executive Vice President, Secretary, Director, Since 2016
Salary: $151,385.00
Bonus: --
Edward Swanson
Chief Operating Officer, Director, Since 2016
Salary: --
Bonus: --
Holly Kramen
Chief Compliance Officer and Privacy Officer, Since 2017
Salary: --
Bonus: --
Michael Neumeister
Chief Medical Officer, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Technology
Industry: Internet Services
Address:

615 S Arapeen Dr
SALT LAKE CITY   UT   84108-1267

Phone: +1385.2372279

PolarityTE, Inc., formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. The Company's PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. The Company focuses on various products, including SkinTE, OsteoTE, AngioTE, MyoTE, CartTE, AdiposeTE and NeuralTE. The Company, through SkinTE, is focused on supplying an autologous construct to regenerate a patient’s skin due to a variety of injuries and conditions.

SPONSORED STORIES